Skip to content

Aehr Test Systems AEHR Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Teradyne, Inc. logo
Teradyne, Inc.TER
FormFactor logo
FormFactorFORM
Amkor Technology logo
Amkor TechnologyAMKR
UCT
Ultra Clean HoldingsUCTT
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
Ralliant Corporation logo
Ralliant CorporationRAL

Other financials

Income statement

See full
Revenue$10.3M-43.7%
Gross profit$3.4M-53.1%
Operating income-$4.2M-278%
Net income-$3.2M-398%
EPS (diluted)-$0.10-400%

Balance sheet

See full
Cash & equivalents$37.1M+18.2%
Total debt$10.0M+55.7%
Total equity$138.8M+11.7%
Total assets$157.0M+7.9%

Cash flow

See full
Operating cash flow-$5.1M-0.9%
CapEx$1.9M-11.1%
Free cash flow-$7.1M+2.7%

Valuation

See full
Market cap$3.22B+424%

Profitability

See full
Gross margin39.5%-8.0pp
Operating margin14.3%+0.7pp
Net margin44.2%+27.4pp

Returns & leverage

See full
Return on equity32.3%+20.3pp
Debt / equity0.1×0.0×
Current ratio11×+5.3×

Where this comes from

Reported directly by Aehr Test Systems in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Aehr Test Systems’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aehr Test Systems's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aehr Test Systems's common stock, shares authorized (in shares)?
Aehr Test Systems (AEHR) reported common stock, shares authorized (in shares) of $75M in Q1 2026.
How has Aehr Test Systems's common stock, shares authorized (in shares) changed year-over-year?
Aehr Test Systems's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $75M to $75M.
What is the long-term trend for Aehr Test Systems's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Aehr Test Systems's common stock, shares authorized (in shares) has grown at a 298.1% compound annual growth rate (CAGR), from $75K to $75M.